Statement on the Label Change for Hycells’s New Product
Release Date:
2024-09-22 14:34
Dear valued customers:
Dear Sir/Madam, We would like to express our heartfelt gratitude for your organization’s unwavering support and trust in Hycells over the years.
To comprehensively enhance the company’s image and brand recognition, Hycells has decided to uniformly upgrade and revamp the labels, instruction manuals, and other materials for its new products. This change is aimed at simplifying complexity and standardizing the presentation of the new products. Visual Recognition Effect. Hycells solemnly promises and guarantees that the manufacturing process, specifications, performance parameters, and other key attributes of the new product will remain unchanged, ensuring no impact on your usage. During the upgrade and iteration period, both new and old packaging will be shipped at random. We apologize for any inconvenience this transition may cause and appreciate your understanding.
If you have any questions or require further assistance, please do not hesitate to contact us. Hycells is committed to providing you with dedicated service. Once again, thank you for your support and attention. We will continue to forge ahead with unwavering determination.
Shanghai Hycells Biotechnology Co., Ltd.
September 19, 2024
Examples of some new and old labels
Tag 1:
Effective immediately, the new version of the Anti-G4S linker tube label for the general-purpose CAR positivity rate assay will be implemented, and the existing label will no longer be used.
♣ New Version Labels
♣ Old Version Label
Tag 2:
Effective immediately, the label on the vial of serum-free γδ T-cell expansion medium will be updated to the new version shown below, and the original label will no longer be used.
♣ New Version Labels
♣ Old Version Label
Related News
HiXpan® Cell Culture Additive: Answers to Key Questions (Part 2)
Hycell’s maximum production capacity per batch is 200–400 units of the 500 mL format, ensuring stable supply and meeting customers’ ongoing production needs.
HiXpan® Cell Culture Additive: Key Questions and Answers (Part 1)
The blood‑derived raw materials used in HiXpan® cell culture additives comply with all regulatory requirements throughout collection, ethical review, informed consent, and commercial authorization, and are supported by a fully traceable supply chain.
This paper focuses on how Hycells transforms biological variability into engineering‑level determinism through a scientifically informed blending strategy and stringent control at the collection end.
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how Hycells proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.
Contact Us
Phone: 021-36696819
Mobile phone:13061948224(Ms. Yu)
Email:monika@hys-bio.com
Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City
Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai
Official Website
WeChat Official Account
Message Board